Anti-NPDC1 (clone W24V117) Recombinant Antibody Coupled Liposome (VS-1024-FY119) (CAT#: VS-1024-FY119)
Liposomes conjugated with anti-NPDC-1 antibodies can be used for the treatment of glioma. This is an emerging targeted drug delivery system that utilizes the specificity of antibodies to enhance the accumulation of drugs at the tumor site, thereby improving therapeutic efficacy. According to existing studies, biologics such as antibodies can be effectively delivered and internalized by being conjugated to liposomes.
More Infomation
Specifications
- Potential Clinical Applications
- Glioma
Product Composition
- Clone
- W24V117
- Antibody Type
- IgG
- Antibody Host
- Mouse
- Antibody Reactivity
- Human
- Antibody Description
- This is a recombinant mouse monoclonal antibody that has been engineered to specifically target human NPDC-1. Designed for precision, this antibody provides researchers with a powerful tool for studying the biochemical and biological functions of NPDC-1 in human cells. Its specific binding affinity allows for enhanced detection and characterization of NPDC-1 in various experimental applications, making it invaluable for advancements in biomedical research.
Product Property
- Storage
- See in the COA
- Storage Shelf Time
- See in the COA
Target Information
- Target
- NPDC1
- Introduction
- Suppresses oncogenic transformation in neural and non-neural cells and down-regulates neural cell proliferation. Might be involved in transcriptional regulation (By similarity).
- Alternative Names
- Neural Proliferation, Differentiation And Control 1; NPDC-1; Neural Proliferation Differentiation And Control Protein 1; CAB-1; CAB1; CAB-; CAB
- Full Name
- Neural Proliferation, Differentiation And Control 1
- Gene ID
- 56654
- UniProt ID
- Q9NQX5
- Sequence Similarities
- Belongs to the NPDC1/cab-1 family.
- Cellular Localization
- Membrane
- Post Translation Modifications
- Glycosylation at Ser114, Thr115, Thr130, and Ser134 ( NX_Q9NQX5 [NX_Q9NQX5-1] )
Modification sites at PhosphoSitePlus ( Q9NQX5 )
Glycosylation from GlyGen (Q9NQX5) 7 sites, 2 O-linked glycans (7 sites)
- Protein Refseq
- NP_056207.3
- Function
- Suppresses oncogenic transformation in neural and non-neural cells and down-regulates neural cell proliferation.
Might be involved in transcriptional regulation (By similarity).
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-1024-FY119. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: WB, IP, IF, FuncS, FC, Neut, ELISA
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: FC, IHC, FuncS, Inhib, Cyt
Application: ELISA, WB, BLI, SPR
-1.jpg)
Application: WB, ELISA, FuncS, Inhib, PK, IP, SPR
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: WB, ELISA, IHC, IP, SPR, FuncS
Application: ELISA, IF, Block, FuncS
Application: ELISA, FC, FuncS
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
